Personality Disorders Foundation Bibliography: Neurobiology

The following resources on personality disorders focus specifically on neurobiology research published since 1997. This portion of the bibliography was compiled by the former Personality Disorders Foundation.


Asberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Annals of the New York Academy of Sciences. 1997 Dec 29;836:158-81. Review.

Brennan PA & Raine A. Biosocial bases of antisocial behavior: Psychophysiological, neurological, and cognitive factors. Clinical Psychology Review. 1997;17(6):589-604. Review.

Cadenhead KS, Light GA, Geyer MA, et al. Neurobiological measures of schizotypal personality disorder: Defining an inhibitory endophenotype? American Journal of Psychiatry. 2002 May;159(5):869-71.

Chatterjee S, Sunitha TA, Velayudhan A, & Khanna S. An investigation into the psychobiology of social phobia: Personality domains and serotonergic function. Acta Psychiatrica Scandinavica. 1997 Jun;95(6):544-50.

Coccaro EF, Kavoussi RJ, Hauger RL, et al. Cerebrospinal fluid vasopressin levels: Correlates with aggression and serotonin function in personality-disordered subjects. Archives of General Psychiatry. 1998 Aug;55(8):708-14.

Coccaro EF, Kavoussi RJ, Sheline YI, et al. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology. 1997 Mar;16(3):211-6.

Constantino JN, Morris JA, & Murphy, DL. CSF 5-HIAA and family history of antisocial personality disorder in newborns. American Journal of Psychiatry. 1997 Dec;154(12):1771-3.

Costa L, Bauer L, Kuperman S, et al. Frontal P300 decrements, alcohol dependence, and antisocial personality disorder. Biological Psychiatry. 2000 Jun 15;47(12):1064-71.

Dickey CC, McCarley RW, Voglmaier MM, et al. Smaller left Heschl's gyrus volume in patients with schizotypal personality disorder. American Journal of Psychiatry. 2002 Sep;159(9):1521-7.

Dolan M, Anderson IM, & Deakin JF. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. British Journal of Psychiatry. 2001 Apr;178(4):352-9.

Gelernter J, Kranzler H, Coccaro EF, et al. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. American Journal of Psychiatry. 1998 155:1332-8.

Gurvits IG, Koenigsberg HW, & Siever LJ. Neurotransmitter dysfunction in patients with borderline personality disorder. Psychiatric Clinics of North America. 2000 Mar;23(1):27-40, vi. Review.

Kavoussi R, Armstead P, & Coccaro E. The neurobiology of impulsive aggression. Psychiatric Clinics of North America. 1997 Jun;20(2):395-403.

Kirrane RM, & Siever LJ. New perspectives on schizotypal personality disorder. Current Psychiatry Reports. 2000 Feb;2(1):62-6.

Laakso MP, Gunning-Dixon F, Vaurio O, et al. Prefrontal volumes in habitually violent subjects with antisocial personality disorder and type 2 alcoholism. Psychiatry Research. 2002 Jun 15;114(2):95-102.

Laakso MP, Vaurio O, Koivisto E, et al. Psychopathy and the posterior hippocampus. Behavioural Brain Research. 2001 Jan 29;118(2):187-93.

Leyton M, Okazawa H, Diksic M, et al. Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. American Journal of Psychiatry. 2001 May;158(5):775-82.

Martial J, Paris J, Leyton M, et al. Neuroendocrine study of serotonin function in female borderline personality disorder patients: A pilot study. Biological Psychiatry. 1997 Oct 15;42(8):737-9.

New AS, Trestman RL, Mitropoulou V, et al. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Research. 1997 Mar 3;69(l):17-26.

Oquendo MA & Mann JJ. The biology of impulsivity and suicidality. Psychiatric Clinics of North America. 2000 Mar;23(1):11-25. Review.

Rosmond R, Baghei F, Holm G, & Bjorntorp P. Relationships between personality disorders and anthropometry, hormones and metabolism in women. Journal of Endocrinological Investigation. 2001 Mar;24(3):159-65.

Sander T, Harms H, Dufeu P, et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biological Psychiatry. 1998 Jun 15;43(12):908-12.

Siever LJ. S6. Genetics and neurobiology of personality disorders. European Psychiatry. 2000 Jun;15(1):54-57.

Silk KR. Borderline personality disorder. Overview of biologic factors. Psychiatric Clinics of North America. 2000 Mar;23(1):61-75. Review.

Soderstrom H, Hultin L, Tullberg M, et al. Reduced frontotemporal perfusion in psychopathic personality. Psychiatry Research. 2002 Jun 15;114(2):81-94.

Soloff P. Special feature: Psychobiologic perspectives on treatment of personality disorders. Journal of Personality Disorders. 1997 Winter;11(4):336-44.

Steinberg BJ, Trestman R, Mitropoulou V, et al. Depressive response to physostigmine challenge in borderline personality disorder patients. Neuropsychopharmacology. 1997 Oct;17(4):264-73.

Svanborg P, Mattila-Evenden M, Gustavsson PJ, et al. Associations between plasma glucose and DSM-III-R cluster B personality outpatients. Neuropsychobiology. 2000 Jan;41(2):79-87.

Veit R, Flor H, Erb M, Hermann C, et al. Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neuroscience Letters. 2002 Aug 16;328(3):233-6.

Verkes RJ, Van der Mast RC, Kerkhof AJ, et al. Platelet serotonin, MAO activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline PD. Biological Psychiatry. 1998 15;43(10):740-6.

Verkes RJ, Fekkes D, Zwinderman AH, et al. Platelet serotonin and [3H]paroxefine binding correlate with recurrence of suicidal behavior. Psychopharmacology (Berl). 1997 Jul;132(l):89-94.


This page was last reviewed by Dr Greg Mulhauser, Thursday, 14 October 2021.